NM_016379.4:c.512A>G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016379.4(VCX3A):c.512A>G(p.Glu171Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016379.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 100356Hom.: 0 Cov.: 18 AF XY: 0.00 AC XY: 0AN XY: 26602 FAILED QC
GnomAD4 exome Cov.: 40
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 100356Hom.: 0 Cov.: 18 AF XY: 0.00 AC XY: 0AN XY: 26602
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.512A>G (p.E171G) alteration is located in exon 3 (coding exon 2) of the VCX3A gene. This alteration results from a A to G substitution at nucleotide position 512, causing the glutamic acid (E) at amino acid position 171 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at